Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1 - PubMed (original) (raw)
. 1995 Jun 22;375(6533):685-8.
doi: 10.1038/375685a0.
Affiliations
- PMID: 7540727
- DOI: 10.1038/375685a0
Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1
J Levitskaya et al. Nature. 1995.
Abstract
The Epstein-Barr virus (EBV)-encoded nuclear antigen (EBNA1) is expressed in latently EBV-infected B lymphocytes that persist for life in healthy virus carriers, and is the only viral protein regularly detected in all malignancies associated with EBV. Major histocompatibility complex (MHC) class I-restricted, EBNA1-specific cytotoxic T lymphocyte (CTL) responses have not been demonstrated. Using recombinant vaccinia viruses encoding chimaeric proteins containing an immunodominant human leukocyte antigen A11-restricted CTL epitope, amino acids 416-424 of the EBNA4 protein, inserted within the intact EBNA1, or within an EBNA1 deletion mutant devoid of the internal Gly-Ala repetitive sequence, we demonstrate that the Gly-Ala repeats generate a cis-acting inhibitory signal that interferes with antigen processing and MHC class I-restricted presentation. Insertion of the Gly-Ala repeats downstream of the 416-424 epitope inhibited CTL recognition of a chimaeric EBNA4 protein. The results highlight a previously unknown mechanism of viral escape from CTL surveillance, and support the view that the resistance of cells expressing EBNA1 to rejection mediated by CTL is a critical requirement for EBV persistence and pathogenesis.
Similar articles
- Epstein-Barr virus isolates with the major HLA B35.01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35.01-positive African population.
Lee SP, Morgan S, Skinner J, Thomas WA, Jones SR, Sutton J, Khanna R, Whittle HC, Rickinson AB. Lee SP, et al. Eur J Immunol. 1995 Jan;25(1):102-10. doi: 10.1002/eji.1830250119. Eur J Immunol. 1995. PMID: 7531142 - Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4.
Gavioli R, Kurilla MG, de Campos-Lima PO, Wallace LE, Dolcetti R, Murray RJ, Rickinson AB, Masucci MG. Gavioli R, et al. J Virol. 1993 Mar;67(3):1572-8. doi: 10.1128/JVI.67.3.1572-1578.1993. J Virol. 1993. PMID: 7679748 Free PMC article. - Contribution of viral recombinants to the study of the immune response against the Epstein-Barr virus.
Delecluse HJ, Feederle R, Behrends U, Mautner J. Delecluse HJ, et al. Semin Cancer Biol. 2008 Dec;18(6):409-15. doi: 10.1016/j.semcancer.2008.09.001. Epub 2008 Sep 30. Semin Cancer Biol. 2008. PMID: 18938248 Review. - Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection.
Rickinson AB, Moss DJ. Rickinson AB, et al. Annu Rev Immunol. 1997;15:405-31. doi: 10.1146/annurev.immunol.15.1.405. Annu Rev Immunol. 1997. PMID: 9143694 Review.
Cited by
- Nowhere to hide: unconventional translation yields cryptic peptides for immune surveillance.
Starck SR, Shastri N. Starck SR, et al. Immunol Rev. 2016 Jul;272(1):8-16. doi: 10.1111/imr.12434. Immunol Rev. 2016. PMID: 27319338 Free PMC article. Review. - Primary CD4+ T-cell responses provide both helper and cytotoxic functions during Epstein-Barr virus infection and transformation of fetal cord blood B cells.
MacArthur GJ, Wilson AD, Birchall MA, Morgan AJ. MacArthur GJ, et al. J Virol. 2007 May;81(9):4766-75. doi: 10.1128/JVI.02608-06. Epub 2007 Feb 21. J Virol. 2007. PMID: 17314172 Free PMC article. - Inhibition of antigen presentation by the glycine/alanine repeat domain is not conserved in simian homologues of Epstein-Barr virus nuclear antigen 1.
Blake NW, Moghaddam A, Rao P, Kaur A, Glickman R, Cho YG, Marchini A, Haigh T, Johnson RP, Rickinson AB, Wang F. Blake NW, et al. J Virol. 1999 Sep;73(9):7381-9. doi: 10.1128/JVI.73.9.7381-7389.1999. J Virol. 1999. PMID: 10438828 Free PMC article. - Immunogenicity of Cas9 Protein.
Mehta A, Merkel OM. Mehta A, et al. J Pharm Sci. 2020 Jan;109(1):62-67. doi: 10.1016/j.xphs.2019.10.003. Epub 2019 Oct 4. J Pharm Sci. 2020. PMID: 31589876 Free PMC article. - Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1.
Tellam J, Connolly G, Green KJ, Miles JJ, Moss DJ, Burrows SR, Khanna R. Tellam J, et al. J Exp Med. 2004 May 17;199(10):1421-31. doi: 10.1084/jem.20040191. J Exp Med. 2004. PMID: 15148340 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials